Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
about
Targeted drugs in small-cell lung cancerSmall cell lung cancer (SCLC): no treatment advances in recent yearsNovel therapies in small cell lung cancerResearch Progression of Maintenance Therapy in Small Cell Lung CancerRisk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase InhibitorsSunitinib: the antiangiogenic effects and beyondTargeting angiogenesis in small cell lung cancerNew and emerging developments in extensive-stage small cell lung cancer therapeuticsAngiogenesis inhibitors for the treatment of small cell lung cancer (SCLC): A meta-analysis of 7 randomized controlled trials.Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials.Small cell lung cancer: will recent progress lead to improved outcomes?Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer.Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.Advances in antiangiogenic treatment of small-cell lung cancer.Bevacizumab in advanced lung cancer: state of the art.Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.Targeted Therapies for Lung Cancer.Maintenance sunitinib for extensive-stage small cell lung cancer: a new standard, an option or a step in the right direction?Progress and challenges in the treatment of small cell lung cancer.Acquired tumor cell resistance to sunitinib by increased invasion and epithelial-mesenchymal transition in LL/2 murine lung cancer.A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting.The 150 most important questions in cancer research and clinical oncology series: questions 86-93 : Edited by Chinese Journal of Cancer.Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07).A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113.[Clinical Development of Immune Checkpoint Inhibitors in Patients with Small Cell Lung Cancer].Phase I study of safety and tolerability of sunitinib in combination with sirolimus in patients with refractory solid malignancies and determination of VEGF (VEGF-A) and soluble VEGF-R2 (sVEGFR2) in plasma.Small Cell Lung Cancer.Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group.Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC).Advanced small cell lung cancer (SCLC): new challenges and new expectations.Immune checkpoint inhibitors in small cell lung cancer.Is the door open to further investigation with antiangiogenesis in SCLC?
P2860
Q26767017-861464BB-F951-4D14-A35D-01606158A163Q26767020-2349218F-BAC4-4C5E-92F7-9F4DB9AF35E6Q26775390-ADB8C3F9-7573-4D18-8CD3-E8629EED90F8Q26783450-8F07D9F8-2B09-4594-9C27-70725CEF95ECQ26851417-1E5457E2-C371-4996-AAC9-74EBBF4476C7Q28066499-56BBFAAC-A168-4C06-BC83-F2C6DE84CAECQ28068385-DFD7C330-0A90-4116-9423-EA1FE90522CBQ28076304-06801923-C05C-42A9-B675-623A16EDEB9CQ30235046-0601BEF0-EF3D-40DF-BFCC-69D0D1760CE7Q33633431-954FDCE7-1BA5-48D8-8CA7-FA8468AB424DQ35836257-48F9902C-7157-4BF8-87E2-CFB0C950D482Q36594253-25172817-9041-45FA-BE22-171964FF7197Q36642545-97BC5900-C87B-4B6A-A801-819CD0466A2BQ36811784-D34229A0-0986-4A87-AEB7-94C8D4EB02A6Q37338005-624112D1-3EEE-469B-8978-1C013EDF954AQ37588040-FD37C269-C48F-4EC7-8611-3CBED36227AAQ38641871-D0BD2A46-DBD8-4115-ADE8-8A0FF142E03CQ38912898-5047D043-7F38-4D61-9156-3051D21295F1Q38930362-F71FB4AD-6517-4910-B0C5-40B703421B46Q38936296-83CAA4F4-BD01-444B-8E38-7848B536ACC8Q39272825-B4330A2F-E69D-4A35-B81F-85546F49AE18Q41876315-BB8DAA41-B3E8-4482-B9F1-E55CC33D19BAQ47320036-0A86071E-D14A-4914-A5CF-B75080F73D8CQ47550252-602DD258-A688-4E00-A536-119E8B466F5CQ47642693-BCE62C74-D350-4A7B-BD77-49EB935805FCQ48374393-6CE03AC8-A0DE-4F60-8B1F-D6BA6F943606Q49958933-778FFA88-C242-4AFD-8F55-611567F1B65AQ52670846-38ADBDEE-40BD-41DB-B359-8B637DB6272BQ52853801-BB0DE365-77B9-4AF1-AF17-99B42BAD6CD4Q53740020-FD4EE9A4-F453-4E1F-928C-F9133C6B5DBFQ53772302-B4440891-96B0-42B9-96A0-0D2830A97649Q54977232-8821A7F2-419D-44F8-B270-2CFD5F49C53DQ55260269-EB4FD53C-CF7E-41B5-884E-AFD3A7CE415AQ55407659-F4AB84DF-CE79-42A2-B79D-8D3E42ACDBF4
P2860
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Chemotherapy With or Without M ...... Study-CALGB 30504 (Alliance).
@ast
Chemotherapy With or Without M ...... Study-CALGB 30504 (Alliance).
@en
type
label
Chemotherapy With or Without M ...... Study-CALGB 30504 (Alliance).
@ast
Chemotherapy With or Without M ...... Study-CALGB 30504 (Alliance).
@en
prefLabel
Chemotherapy With or Without M ...... Study-CALGB 30504 (Alliance).
@ast
Chemotherapy With or Without M ...... Study-CALGB 30504 (Alliance).
@en
P2093
P2860
P356
P1476
Chemotherapy With or Without M ...... Study-CALGB 30504 (Alliance).
@en
P2093
Antonius A Miller
Gregory A Masters
Gregory A Otterson
Jeffrey Bogart
Jeffrey Crawford
Maria Baggstrom
Neal E Ready
Sachdev P Thomas
Stephen L Graziano
P2860
P304
P356
10.1200/JCO.2014.57.3105
P407
P577
2015-03-02T00:00:00Z